ALS - Overview

ALS - Treatment

ALS - Dietary Strategy

ALS - Exercise Strategy

ALS - Stress



FDA Gives Orphan Drug Designation to Ketamine for ALS

The FDA has recently given orphan drug designation to Ketamine for treatment of Amyotrophic Lateral Sclerosis (ALS)


Trial Shows Arthritis Treatment Safe for ALS and Eases Inflammation

Tocilizumab, an established rheumatoid arthritis (RA) treatment, was found to reduce inflammation in ALS patients in a new study.


Cholesterol Metabolism Defects Linked to ALS

A new study published in the Journal of Cell Biology has linked a defect in cholesterol metabolism to the development of neurological damage caused by amyotrophic lateral sclerosis (ALS).

Send this to a friend